Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor.

作者: Fathima R. Kona , Karri Stark , Luke Bisoski , Daniela Buac , Qiuzhi Cui

DOI: 10.1007/S10549-012-2107-4

关键词:

摘要: RNF115, or Breast Cancer-Associated Gene 2 (BCA2), encodes a RING-finger ubiquitin E3 ligase, expression of which was associated with estrogen receptor (ER)-positive status in human breast tumors. Although the BCA2 promoter contains several response element (ERE) half-sites, role ER regulation transcription has not been reported. The aim this study is to investigate molecular mechanism by regulates transcription. mRNA and protein levels were examined RT-PCR Western blot analysis, respectively, localization assessed immunofluorescence. activity E2 tested dual luciferase reporter assay binding chromatin immunoprecipitation assay. We found that are regulated ER-positive MCF7 cancer cells MDA MB 231 stably transfected ER. Estrogen treatment hormonal depleted 231/ER resulted increased nuclear cytoplasmic staining. Cycloheximide able inhibit levels, suggesting potential at transcriptional level. Anti-estrogens like tamoxifen ICI 182 178 counteracted E2-induced knockdown siRNA significant decrease lower pattern. lead increase response, ERE region promoter. therefore newly identified target receptor.

参考文章(43)
Lucia Altucci, M Beato, F Bresciani, M Truss, Mg Parker, A. Weisz, L Cicatiello, S Dauvois, Sica, R Addeo, 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene. ,vol. 12, pp. 2315- 2324 ,(1996)
W. L. McGuire, G. C. Chamness, Studies on the Estrogen Receptor in Breast Cancer Advances in Experimental Medicine and Biology. ,vol. 36, pp. 113- 136 ,(1973) , 10.1007/978-1-4684-3237-4_7
J.D. Furlow, F.E. Murdoch, J. Gorski, High affinity binding of the estrogen receptor to a DNA response element does not require homodimer formation or estrogen Journal of Biological Chemistry. ,vol. 268, pp. 12519- 12525 ,(1993) , 10.1016/S0021-9258(18)31419-4
Peter J. Kushner, David Agard, Wei-Jun Feng, Gabriela Lopez, Andrew Schiau, Rosalie Uht, Paul Webb, Geoffrey Greene, Oestrogen receptor function at classical and alternative response elements. Novartis Foundation symposium. ,vol. 230, pp. 20- 32 ,(2000) , 10.1002/0470870818.CH3
Robert P. C. Shiu, Thomas C. Dembinski, Don Dubik, Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Research. ,vol. 47, pp. 6517- 6521 ,(1987)
Philippe Walker, Jacques-Edouard Germond, Marianne Brown-Luedi, Françoise Givel, Walter Wahli, Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDLII genes Nucleic Acids Research. ,vol. 12, pp. 8611- 8626 ,(1984) , 10.1093/NAR/12.22.8611
W. Porter, B. Saville, D. Hoivik, S. Safe, Functional Synergy between the Transcription Factor Sp1 and the Estrogen Receptor Molecular Endocrinology. ,vol. 11, pp. 1569- 1580 ,(1997) , 10.1210/MEND.11.11.9916
Carolyn M. Klinge, April L. Studinski-Jones, Peter C. Kulakosky, Robert A. Bambara, Russell Hilf, Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements. Molecular and Cellular Endocrinology. ,vol. 143, pp. 79- 90 ,(1998) , 10.1016/S0303-7207(98)00130-0